Yahong Pharmaceuticals: It is expected that the annual net loss will be between 378 million to 453 million yuan in 2025.

Yahong Pharmaceuticals announced that the estimated net loss attributable to the owners of the parent company in 2025 is expected to be between 378 million yuan and 453 million yuan, an increase in net loss of 69.1351 million yuan to 6.398 million yuan compared to the same period last year. The company's estimated operating income for 2025 is around 242 million yuan to 291 million yuan, an increase of 40.9189 million yuan to 89.4152 million yuan compared to the same period last year, with a year-on-year growth of 20.30% to 44.36%.